- Spirometry peculiarities in children with different degrees of bronchial asthma controllability
Spirometry peculiarities in children with different degrees of bronchial asthma controllability
SOVREMENNAYA PEDIATRIYA.2017.2(82):97-101; doi 10.15574/SP.2017.82.97
Rechkina О. О., Rudenko S. M., Doroshenkova F. S., Kravtsova O. M.
State Institution «National institute of phthisiology and pulmonology named after F.G. Yanovskyi of NAMS of Ukraine», Kyiv
Objective. To study and estimate the respiratory function (RF) in children with bronchial asthma (BA) with different degrees of disease control.
Materials and methods. The estimation of RF in 111 children with different degrees of asthma control was performed. Children's age ranged from 5 to 17 years, mean age — 10.61±0.33 years.
Results. Prior to the test with bronchodilators, the obstructive type of respiratory impairment detected in 30 (27 %) cases of examined children. Reversibility of indicators was found in 63 (57 %) children during the test. An increase of the forced expiratory volume in one second (FEV1) in children with uncontrolled asthma (14.45±3.04 %) was significantly higher (p<0.05) compared with those in children with partial control (7.26 ± 1.09 %) and controlled course of the disease (6.4±2.05%). An increase of the maximal expiratory flow rate at 25 % of vital capacity (MFR25) was not significantly different in children with controlled (24.47 ± 5.54%), partially controlled (27.53 ± 4.11%) and uncontrolled (36.28 ± 6.61%) BA, which indicates a severe disorder at the level of small bronchi in children with controlled and partially controlled BA.
Conclusions. In children with BA a persisting change of RF of obstructive type, the abnormalities of lower respiratory tract, commonly of concealed nature, were observed. The «FEV1<80%» criterion of controllability has a low sensitivity in estimating the degree of BA control in children, while changes of MFR25 are more sensitive and manifest since before the changes of FEV1.
Key words. Spirometry, children, asthma, asthma control, MEF25.
1. Anokhin MI. Geppe NA, Putyata TG. 2012. Experience bronchodilator spirometric assessment tests and provocative stress test in children with moderate controlled asthma. Pediatrics. 91; 2: 112-115.
2. Anokhin MI. 2003. Spirography children. M, Medicine: 120.
3. Polyakov VV, Senatorova AS. 2009. Funktsional assessment of pulmonary ventilation in children with asthma in remission. Odesky medichny journal. 4(114): 40-43.
4. Saveliev BP, Shiryaev IS. 2001. Functional parameters of the respiratory system in children and adolescents: a guide for physicians. M, Medicine: 232.
5. Order of the Ministry of Health of Ukraine of 08.10.2013 No.868. The unified clinical protocol of primary, secondary health care "Bronchial asthma in children. 2013.
6. Casale Th, van Wijk RG. 2008. Guidelines for Treatment of Pediatric Asthma. JAMA (Print ISSN: 0098-7484; Online ISSN: 1538-3598). 299; 24: 2855.
7. Stout JW, Visness CM, Enright P, Lamm C, Shapiro G, Gan VN et al. 2006. Classification of asthma severity in children: the contribution of pulmonary function testing. Arch Pediatr Adolesc Med. 160: 844-850. https://doi.org/10.1001/archpedi.160.8.844; PMid:16894085
8. Galant SP, Morphew T, Newcomb RL. 2011. The relationship of bronchodilator response phenotype to poor asthma control in children with normal spirometry. J Pediatr. 158(6): 953–959. https://doi.org/10.1016/j.jpeds.2010.11.029; PMid:21232757 PMCid:PMC3160763
9. Global strategy for asthma management and prevention (GINA 2015). http://www.ginasthma.
10. Nair S, Daigle K, DeCuir P, Lapin C, Schramm C. 2005. The influence of pulmonary function testing on the management of asthma in children. J Pediatr. 147: 797-801. https://doi.org/10.1016/j.jpeds.2005.07.023; PMid:16356434
11. White EA, Jones PW. 1996. Morning and evening peak flow and spirometry as correlates of life in asthma. Amer J Respir Crit Care Med. 513(2): 772—774.
12. Asher M, Montefort IS, Björkstén B, Lai CKW, Strachan DP, Weiland SK, Williams H. 2006. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. ISAAC Phase Three Study Group. The Lancet. 368: 733 – 743. https://doi.org/10.1016/S0140-6736(06)69283-0